The UK biotech and pharmaceuticals industry is a major success story. Earnings from exports of medicines exceeded £7 billion in 2009 and the industry has been a net earler for Britain throughout all of the past 30 years. The country has expertise in all areas of the supply chain from research and discovery through manufacturing and clinical trials, to marketing and distribution.
In order to ensure the UK remains a world leader in this area, government, academic and industry must support the next wave of technology, which can deliver the products of the future. Nanotechnology is one area that promises to provide that innovation.
NanoPharm looks at the opportunities nanotech offers, what the barriers to adoption are and to advise government on strategy, funding and the needs of industry.